Sichuan University

This study tests whether adding radiotherapy to immunotherapy and chemotherapy can help people with advanced small cell lung cancer that has spread to the liver. It includes 30 adults aged 18-75 who have already tried standard treatments. The goal is to see if the combination shr…

This study tests whether adding the drug ivonescimab to standard chemotherapy (SOX) works better than chemo alone for people with locally advanced stomach or gastroesophageal junction cancer. About 154 adults will receive treatment every 3 weeks for 4 months before surgery. The m…

This early-phase trial tests a new mRNA drug (WGb-0301) for people with B-cell blood cancers that have come back or not responded to standard treatments. The drug uses lipid nanoparticles to deliver mRNA that targets CD19 on cancer cells, aiming to clear them safely. Only 9 parti…

This early study tests a new medicine called WGb-0302 for people with blood cancers like multiple myeloma that have returned or not responded to other treatments. The drug uses mRNA technology (similar to some COVID-19 vaccines) to help the body attack cancer cells. About 20 adul…

This study tests a combination of two drugs, sacituzumab tirumotecan and anlotinib, in people with extensive-stage small cell lung cancer whose cancer has come back after prior treatment. The goal is to see if the combo can shrink tumors and delay cancer growth. About 33 adults a…

This early-stage trial tests a new approach for people with recurrent or metastatic head & neck cancer or esophageal cancer. The treatment combines a virus-based gene therapy (injected directly into tumors) with an immunotherapy drug. The main goals are to check safety and find t…

This study tests whether having patients regularly report their own symptoms (like pain or nausea) after esophageal cancer surgery leads to better recovery than standard care. About 240 adults in China will take part. The goal is to see if this approach reduces complications and …